Overview

The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
Primary outcome: Serum creatinine change at 4 hours and 48 hours following 4 doses of N-acetylcysteine (total 4800 mg) compared to baseline serum creatinine. Secondary outcome: Serum Cystatin C change at 4 hours and 48 hours post 4 doses of N-acetylcysteine compared to baseline serum Cystatin C.
Phase:
N/A
Details
Lead Sponsor:
University of Vermont
Collaborator:
FlowMedic
Treatments:
Acetylcysteine
N-monoacetylcystine